baht or 112.4%. Financial cost increased due to the Company incurred more debentures and loan from financial institution. Summary of Financial Statement of Position 31-Dec-16 31-Dec-17 Change MB % MB

decreased when compared to December 31, 2018 was 2,594.08 Million Baht due to the company has loss from business operation Please be informed for acknowledgement, Sincerely yours, Mr. Wutichai Leenabanchong

Baht which was lower than the same period last year 30% due to the reduction of rental and service revenues. Service and Administrative Expenses The Company had service and administrative expenses for

thereby incurred high amount of such fee. Financing Costs Financing cost significantly decreased in 2017 due to the Company and its subsidiary applied the proceeds derived from the initial public offering

baht, With an increase of 122.48 million Baht equal to 98.65%. Due to the company had the authorized to know the income from WICE (Hong Kong) Limited. For this Quarter the company had receive the new

net increase of Baht 243.51 million due to the company having the collaboration with its key distributors in order to continually expand distribution channels and increase sales promotions. For other

446 million increased by 24% compared 3 to the same period in the previous year, due to the Company plans to develop salesman and products. Gross margin in Q1/2019 from distributor of medical devices

143.77 million Baht, revenue in 2018 amount of 144.34 million Baht. First 6 months revenue decreased 0.57 million Baht or 0.39% compared to the same period of the last year due to the Company and its

production to order increased by 100% due to the Company was enough capacity to services. However, the Company is considering to provide service that are suitable situation of the Company. 2. Other Income

  increasing  of  Baht  0.23  million  or  0.28%  when  comparing to the 2nd quarter of year 2017 which was Baht 84.66 million due to:       DEMCO Public Company Limited Sales  and  administrative  expenses